Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
AURYXIA (FERRIC CITRATE), AN ORAL IRON-BASED PHOSPHATE BINDER SIGNIFICANTLY IMPROVES SERUM IRON MEASURES IN PATIENTS WITH STAGE 3, 4 AND 5 CHRONIC KIDNEY DISEASE (CKD) Fishbane, S., Block, G. A., Loram, L. C., Chertow, G. M. W B SAUNDERS CO-ELSEVIER INC. 2015: A35
View details for Web of Science ID 000355796500086